Summary
This prediction ended on 12.09.12 with a price of €127.68. The BUY prediction by melinda finished with a performance of 8.66%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Carmat | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
According to melinda what are the pros and cons of Carmat for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Carmat diskutieren
künstliches Herz
CARMAT ist die Medizintechnik Start-up, wenn das Herz voll implantierbaren Herzunterstützungssystem oder eine Transplantation fehlgeschlagen oder nicht möglich sind (wie auf seine Dreharbeiten Fenster)
(Vom Mitglied beendet)